India’s HIV infections are rising quietly. Why twice-yearly lenacapavir matters

The Central Drugs Standard Control Organisation CDSCO has permitted two Indian drugmakers to make generic lenacapavir without local clinical trials amid a steady and worrying rise of new HIV infections in many states in the country